Decoding colorectal cancer targeted therapy: a bibliometric journey of the last decade (2015–2024)
Abstract Colorectal cancer remains one of the most commonly diagnosed cancers globally, with a significant impact on public health. Targeted therapies have revolutionized the treatment landscape for colorectal cancer by offering increased specificity and reduced systemic toxicity compared to convent...
Saved in:
| Main Authors: | Linpo Zhou, Xuanwei Huang, Jing Shi, Yebin Yang, Fanhe Dong, Haoran Wei, Chenghao Ji, Yuqiang Shan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02251-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effectiveness of three months EGFR-CTH therapy in palliative colorectal cancer
by: Maciej Pawel Jankowski, et al.
Published: (2025-01-01) -
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer
by: Huilin Cui, et al.
Published: (2024-11-01) -
EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer
by: Dana Krauß, et al.
Published: (2025-05-01) -
Gasdermin D regulates the activation of EGFR in colorectal cancer
by: Ying Li, et al.
Published: (2024-12-01) -
The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
by: Abdo Meyiah, et al.
Published: (2025-03-01)